期刊文献+

SARS与普通肺炎的临床特征对比分析 被引量:1

Comparative Study of Clinical Characteristics between Patients with SARS and Classic Pneumonia
下载PDF
导出
摘要 目的:对SARS与普通肺炎的临床特征进行对比分析。方法:以122例SARS和95例普通肺炎病例为对象,比较两组病例的流行病学、临床特征、实验室检查和影像学检查等资料的差异。结果:SARS组和对照组的气促(118/122 vs 38/95,P<0.01)和全身酸痛(53/122 vs 12/95,P<0.01)出现率、平均发热持续时间(9.46±8.10)d vs (6.15±7.12) d(t=2.829 d,P<0.01)、出现低氧血症的例数(45/122 vs 19/95,x^2=7.32,P<0.01)、病灶高峰时平均受累肺叶数(2.20±1.6)d vs (1.01±0.96) d(t=3.088,P<0.01)和平均病程(25.9±15.0)d vs (17±13.2) d(t=4.622,P<0.001)以及并发症出现例数(37/122 vs 16/95,x^2=5.26,P<0.05)均有显著或极显著性差异。结论:与普通肺炎病例相比,SARS病例的发热、气促和全身酸痛等症状及低氧血症更明显,同时,病灶范围更为广泛,并发症、脏器功能损害的出现率更高。 Objective: To investigate and study comparatively the clinical characteristic between patients with SARS and classic pneumonia. Methods: 122 patients with SARS and 95 patients with classic pneumonia were retrospectively studied. The data on epidemiology, clinical characteristics, laboratory tests and x-ray detections of the two groups were compared. Results: The rates of patients with dyspnea and body ache in group SARS were higher than those in group classic pneumonia(P<0.01, P<0.01). There were markedly difference in average duration of fever (9.46±8.10) days vs (6.15±7.12) days (t=2.829, P<0.01), number of patients with hypoxemia(45/122 vs 19/95 x^2=7.32, P<0.01), complications (37/122 vs 16/95, x^2=5.26, P<0.05), lobes affected (2.20±1.6 vs 1.01±0.96, t=3.088, P<0.01) and course of diseases (25.9±15.0) days vs (17.04±13.18) days (t=4.622, P<0.001) between patients with SARS and classic pneumonia. Conclusions: The symptoms of fever, dyspnea body ache and hypoxemia in patients with SARS were severer than those in patients with classic pneumonia. There were larger scale of foci in lungs and higher rate of complications and dysfunction of organs in patients with SARS.
出处 《广州医学院学报》 2004年第2期26-29,共4页 Academic Journal of Guangzhou Medical College
基金 国家自然科学基金(40332024)
关键词 SARS 肺炎 临床特征 SARS pneumonia clinical characteristics
  • 相关文献

参考文献7

二级参考文献12

  • 1Bernard GR, Artigas, Brighan KL, et al. Report of the american european consensus conference on ARDS :definitions, mechanism,relevant outcomes and clinical trial coordinations. Intensive Care Med, 1994 ,20:225-232.
  • 2Saikku P. Atypical respiratory pathogen. Clin Microbiol Infect, 1997,3:599-604.
  • 3Lee SJ, Lee MG, Jeon MJ, et al. Atypical pathogens in adult patients admitted with community-acquired pneumonia in Korea. Jpn J Infect Dis, 2002 ,55:157-159.
  • 4Chan PK. Outbreak of avian influenza A( H5N1 ) virus infection in Hong Kong in 1997. Clin Infect Dis, 2002 1 ;34 Suppl 2:S58-64.
  • 5Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet, 351:467-471.
  • 6Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Eng J Med, www. nejm.org. on March 31,2003.
  • 7Ksiazek TG, Erdman D, Goldsmith C et al. A novel coronavirus associated with severe acute respiratory syndrome. New Eng J Med2003, April 10th www. nejm. org
  • 8Peiris JSM, Lai ST, Poon, LLM et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 2003, 361:9366.
  • 9Osterhaus A. Severe acute respiratory syndrome- WHO press briefing Palais des Nation, 16th April 2003 www. who. int/csr/sars/2003.
  • 10Peers SH. The role of lipocortin in corticosteroid actions. Am Rev Respir Dis, 1990, 141(2 Pt 2):18.

共引文献1266

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部